MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    A Case of Mitochondrial Membraine Protein-Associated Neurodegeneration with Progressive Parkinsonism in a Young Male

    B. Akkineni, L. Teshome, E. Krause (Austin, USA)

    Objective: N/a Background: Less than a hundred cases of mitochondrial membrane protein-associated neurodegeneration (MPAN) have been reported thus far in literature. We present a case…
  • 2025 International Congress

    Diverse clinical phenotypes of ATP1A3 mutations-A case series of four patients

    S. Rath, V. Holla, P. Pal, N. Kamble, R. Yadav (BANGALORE, India)

    Objective: To study the clinical phenotype of all patients with ATP 1A3 mutation in the genetic study Background: ATP1A3 is associated with a broad spectrum…
  • 2025 International Congress

    Stepping backwards to move forward A case study on novel PT interventions for DLB

    K. Vasher, A. Boddy (Loma Linda, USA)

    Objective: Explore the effectiveness of backwards walking and backwards stepping interventions to improve gait stability and balance in persons with Dementia with Lewy Bodies (DLB).…
  • 2025 International Congress

    4R-TAU seed amplification assay discriminates tauopathies from non-tauopathies and CBD from PSP in post-mortem brain samples

    L. de Mena, M. Fernandez, J. Perez, C. Painous, A. Camara, A. Perez-Soriano, L. Molina-Porcel, E. Artikis, B. Caughey, Y. Compta (Barcelona, Spain)

    Objective: To investigate whether 4R-TAU seed amplification assay discriminates tauopathies from non-tauopathies as well as CBD from PSP in post-mortem brain samples. Background: 4 repeat…
  • 2025 International Congress

    Neurogenic bladder and affective disorders in parkinsonism

    E. Korshunova, M. Khommyatov, M. Samushiya, N. Suponeva (Moscow, Russian Federation)

    Objective: To determine the relationship between psychoemotional and dysuria dysfunctions in patients with PD and MSA. Background: In the group of patients with extrapyramidal pathology…
  • 2025 International Congress

    Unraveling Functional Overlay in Parkinson’s Disease: A Diagnostic Challenge

    RAM. Carandang, P. Panyakeaw (Bangkok, Thailand)

    Objective: To highlight the diagnostic complexities of functional movement disorders (FMD) in Parkinson’s disease (PD) and the role of neurophysiological studies in differentiating functional overlay…
  • 2025 International Congress

    Efficacy And Safety of Fecal Microbiota Transplant for Parkinson’s Disease: A Systematic Review And Meta-Analysis

    A. Koppanatham, A. Bin Gulzar, M. Ammar Arshad, E. de Farias, V. Suresh, M. Tariq, R. Vasireddy, T. Varkey (Lahore, Pakistan)

    Objective: To evaluate the efficacy and safety of Fecal Microbiota Transplantation (FMT) in patients with Parkinson’s disease (PD). Background: FMT is a novel therapy for…
  • 2025 International Congress

    Broad spectrum local field potential activities as a novel biomarker for adaptive deep brain stimulation

    CH. Tai, YC. Lin, WH. Hu, MT. Hsu, SH. Tseng (Hsinchu, Taiwan)

    Objective: This study aims to evaluate the wider frequency range (1-200 Hz) LFPs as the novel neural biomarkers for adaptive DBS. In parkinsonism rats, we…
  • 2025 International Congress

    Parkinson’s Disease and Cancer: A Meta-Analysis of Prevalence, Risk, and Specific Associations with Brain and Skin Cancers

    H. Khelifa, A. R. Al-Ihribat, H. Smeda, A. Hendawy, A. Abunamoos (Oran, Algeria)

    Objective: To update the available data on the prevalence of cancer among patients with Parkinson’s Disease (PD) and the prevalence of PD among cancer patients…
  • 2025 International Congress

    Clinical and neuro-imaging predictors of falls in PLA2G6-related Parkinsonism: a retrospective study

    C. Chen, Y. Sun, H. Dai, F. Liu, . Jun, X. Liu, J. Wang (Shanghai, China)

    Objective: This study investigates clinical and neuroimaging predictors of recurrent falls and gait disturbances in PLA2G6-related Parkinsonism. Background: PLA2G6-related Parkinsonism is characterized by dystonia-parkinsonism, cerebellar…
  • 1
  • 2
  • 3
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley